VK

Vankayalapati Karunakar

Active Director Designated Partner DIN 08669219
DIN 08669219 First appointment Jan 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Vankayalapati Karunakar

Data last updated:

Vankayalapati Karunakar is a Designated Partner at Ravatis Pharmaceuticals Llp (since 2020). The company operates in Healthcare.

DIN 08669219
Primary Designation Designated Partner
Industry Healthcare
First Appointment 15 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Jan 20202020Active

Board colleagues of Vankayalapati Karunakar

NameDINCompanyDesignation
Narasimha Rao Balasudhakar Maduri08669220Ravatis Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ravatis Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Vankayalapati Karunakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vankayalapati Karunakar

Vankayalapati Karunakar currently holds 1 directorship: Ravatis Pharmaceuticals Llp (Designated Partner, since 15 Jan 2020).

Vankayalapati Karunakar was first appointed on 15 Jan 2020 as Designated Partner at Ravatis Pharmaceuticals Llp.

The current boards of Vankayalapati Karunakar's companies include Narasimha Rao Balasudhakar Maduri (Ravatis Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available